Vice President, In Vivo Cell Therapies · Velvet Therapeutics · company speakers →
Dr. Bagashev is the VP of In Vivo Cell Therapies at Velvet Therapeutics, where he leads strategic development of next-generation CAR based immunotherapies. He brings extensive expertise in immuno-oncology and cell therapies, with publications spanning engineered CAR constructs and immune-modulating platforms. Previously, at Carisma Therapeutics, he advanced preclinical proof-of-concept in vivo CAR-M programs for solid tumors using mRNA/LNP delivery systems. Before Carisma Therapeutics, he contributed to translational ex vivo CAR-T research at Children’s Hospital of Philadelphia and the University of Pennsylvania. His work integrates synthetic biology, vector engineering, and tumor immunology to develop scalable and affordable In Vivo CAR cellular therapies for solid tumors.
Is this you? Claim this profile →
No public contact links on file.
Sectors
Sourcing speakers for your event?
Browse the speaker directory →